the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Najib slapped with 15 years’ jail over 1MDB conviction

Former prime minister found guilty of power abuse and money laundering involving RM2.3 billion from 1MDB funds, fined RM11.4 billion

PUTRAJAYA: Datuk Seri Najib Abdul Razak has been sentenced to a period of 15 years’ imprisonment by the High Court for financial crimes involving 1Malaysia Development Berhad (1MDB) while in power between 2009 and 2018.

The sentences were handed down this evening after the former prime minister was earlier today found guilty on four charges of abusing his power and 21 counts of money laundering involving RM2.3 billion from 1MDB funds.

The jail terms for all counts, which accumulate to 165 years, are to run concurrently.

He was also fined a total of RM11.4 billion.

In effect, the maximum period that he will have to serve is 15 years.

READ MORE: Najib guilty over RM2.3billion 1MDB funds

The verdict and the sentencing were ruled by Justice Datuk Collin Lawrence Sequerah, who has presided over the 1MDB trial as a judge in the High Court, before his recent elevation to the Federal Court.

Najib is presently already serving time at Kajang Prison for the misappropriation of RM42 million from SRC International Sdn Bhd.

The sentence will take effect after Najib completes his present six-year prison term for his previous conviction, which ends on Aug 23, 2028.

Justice Sequerah also ordered that the former Prime Minister serve a 40-year prison term in default of payment of the fine.

ALSO READ: Najib found guilty on all 1MDB-related charges

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings